Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$4.1 - $5.33 $67,502 - $87,753
-16,464 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$4.93 - $7.15 $216,984 - $314,692
-44,013 Reduced 72.78%
16,464 $83,000
Q4 2020

Feb 16, 2021

SELL
$4.55 - $7.29 $293,020 - $469,476
-64,400 Reduced 51.57%
60,477 $382,000
Q3 2020

Nov 16, 2020

BUY
$4.22 - $6.04 $92,637 - $132,590
21,952 Added 21.33%
124,877 $537,000
Q2 2020

Aug 17, 2020

BUY
$3.76 - $8.01 $386,998 - $824,429
102,925 New
102,925 $604,000

Others Institutions Holding CBIO

# of Institutions
1
Shares Held
215
Call Options Held
0
Put Options Held
0

About CATALYST BIOSCIENCES, INC.


  • Ticker CBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,477,100
  • Description
  • Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...
More about CBIO
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.